scholarly journals What’s New with Flu? An Overview

Viruses ◽  
2019 ◽  
Vol 11 (5) ◽  
pp. 433 ◽  
Author(s):  
Seema S. Lakdawala ◽  
Christopher B. Brooke
Keyword(s):  
Public Health ◽  
Influenza Viruses ◽  
H1n1 Pandemic ◽  
Global Public Health ◽  
Health Threat ◽  
Public Health Threat

One hundred years have passed since the 1918 H1N1 pandemic, and influenza viruses continue to pose an enormous and unpredictable global public health threat [...]

scholarly journals Arboviruses: A global public health threat

Vaccine ◽  
2020 ◽  
Vol 38 (24) ◽  
pp. 3989-3994 ◽  
Author(s):  
Marc Girard ◽  
Christopher B. Nelson ◽  
Valentina Picot ◽  
Duane J. Gubler
Keyword(s):  
Public Health ◽  
Global Public Health ◽  
Health Threat ◽  
Public Health Threat

scholarly journals Genomic surveillance of SARS-CoV-2 in Thailand reveals mixed imported populations, a local lineage expansion and a virus with truncated ORF7a

2020 ◽  
Author(s):  
Elizabeth M Batty ◽  
Theerarat Kochakarn ◽  
Bhakbhoom Panthan ◽  
Krittikorn Kümpornsin ◽  
Poramate Jiaranai ◽  
...  
Keyword(s):  
Public Health ◽  
Global Public Health ◽  
Health Threat ◽  
Frame Shift ◽  
Public Health Threat

AbstractCoronavirus Disease 2019 (COVID-19) is a global public health threat. Genomic surveillance of SARS-CoV-2 was implemented during March 2020 at a major diagnostic hub in Bangkok, Thailand. Several virus lineages supposedly originated in many countries were found, and a Thai-specific lineage, designated A/Thai-1, has expanded to be predominant in Thailand. A virus sample in the SARS-CoV-2 A/Thai-1 lineage contains a frame-shift deletion at ORF7a, encoding a putative host antagonizing factor of the virus.

scholarly journals Landscape Coronavirus Disease 2019 test (COVID-19 test) in vitro -- A comparison of PCR vs Immunoassay vs Crispr-Based test

2020 ◽  
Author(s):  
Huajun Bai ◽  
Xiaolong Cai ◽  
Xiaoyan Zhang
Keyword(s):  
Public Health ◽  
Global Public Health ◽  
Rt Pcr ◽  
Health Threat ◽  
The World ◽  
Public Health Threat ◽  
Novel Coronavirus

The outbreak of COVID-19, caused by 2019 novel coronavirus (2019-nCoV), has been a global public health threat and caught the worldwide concern. Scientists throughout the world are sparing all efforts to explore strategies for the determination of the 2019-nCoV virus and diagnosis of COVID-19 rapidly. Several assays are developed for COVID-19 test , including RT-PCR, coronavirus antigens-based immunoassays, and CRISPR-based strategies (Cas13a or Cas12a), etc. Different assays have their advantages and drawbacks, and people should choose the most suitable assay according to their demands. Here, we make a brief introduction about these assays and give a simple overview of them, hoping to help doctors and researchers to select the most suitable assay for the Coronavirus Disease 2019 test (COVID-19 test) .

scholarly journals The Emergence of Extensively Drug-Resistant Tuberculosis (TB): TB/HIV Coinfection, Multidrug-Resistant TB and the Resulting Public Health Threat from Extensively Drug-Resistant TB, Globally and in Canada

2007 ◽  
Vol 18 (5) ◽  
pp. 289-291 ◽  
Author(s):  
Paul E Alexander ◽  
Prithwish De
Keyword(s):  
Public Health ◽  
Multidrug Resistant ◽  
Current Status ◽  
Drug Resistant ◽  
Global Public Health ◽  
Access To Treatment ◽  
Health Threat ◽  
Extensively Drug Resistant ◽  
Hiv Coinfection ◽  
Public Health Threat

Resistance to anti-tuberculosis (TB) drugs continues to present a major challenge to global public health. Resistance usually develops due to inadequate TB management, including improper use of medications, improper treatment regimens and failure to complete the treatment course. This may be due to an erratic supply or a lack of access to treatment, as well as to patient noncompliance. However, the emergence and transmission of drug-resistant TB, including the recently detected extensively drug resistant TB (XDR-TB), is driven, in part, by the synergistic relationship between TB and HIV (TB/HIV coinfection). There is evidence that persons infected with HIV are more likely to experience XDR-TB. XDR-TB is virtually untreatable with available TB medications. XDR-TB presents a grave global public health threat, particularly in high HIV prevalence settings. The present commentary discusses the current status of XDR-TB and draws attention to the urgency in addressing this problem, for both the global and Canadian public health networks. XDR-TB and the apparent XDR-TB and HIV association warrants further study.

Sign in / Sign up

Export Citation Format

Share Document